Maxigen BiotechTPE:1783 +2.70%87 Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus rates TPE:1783 with a GF Score™ of 87/100 and a GF Value™ of NT$61.11 (Significantly Undervalued). Among 281 Medical Devices & Instruments companies, Maxigen Biotech ranks better than 70.46% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Maxigen Biotech's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Maxigen Biotech's Dividend Payout Ratio or its related term are showing as below:
TPE:1783'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.44 Max: 0.86
Current: 0.29
During the past 13 years, the highest Dividend Payout Ratio of Maxigen Biotech was 0.86. The lowest was 0.19. And the median was 0.44.
TPE:1783's Dividend Payout Ratio is ranked better than 70.46% of 281
companies
in the Medical Devices & Instruments industry
Industry Median: 0.42
vs TPE:1783: 0.29
During the past 12 months, Maxigen Biotech's average Dividends Per Share Growth Rate was -16.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Maxigen Biotech was 69.50% per year. The lowest was -9.50% per year. And the median was 16.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Maxigen Biotech (TPE:1783) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Maxigen Biotech Dividend Payout Ratio Related Terms
Maxigen Biotech Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Maxigen Biotech's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1783 vs ISRG, BDX, MDLN: Dividend Payout Ratio Comparison
For the Medical Instruments & Supplies subindustry, Maxigen Biotech's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maxigen Biotech Dividend Payout Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Maxigen Biotech's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Maxigen Biotech's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maxigen Biotech (TPE:1783) has a Dividend Payout Ratio of 0.00 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Maxigen Biotech and its competitors. Over the past decade, Maxigen Biotech's Dividend Payout Ratio has ranged from 0.19 to 0.86. According to the industry distribution chart, Maxigen Biotech ranks #83 out of 281 companies in the Medical Devices & Instruments industry, placing it in the top 29.5%.
Is Maxigen Biotech's Dividend Payout Ratio too high?
Maxigen Biotech's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 0.86. Based on the distribution chart, Maxigen Biotech ranks #83 out of 281 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Maxigen Biotech has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maxigen Biotech's Dividend Payout Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Maxigen Biotech ranks #83 out of 281 companies for Dividend Payout Ratio. This puts Maxigen Biotech in the upper half of its industry. The industry median Dividend Payout Ratio is 0.42. Historically, Maxigen Biotech's own Dividend Payout Ratio has ranged from 0.19 to 0.86 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Devices & Instruments company?
The median Dividend Payout Ratio among Medical Devices & Instruments companies is 0.42, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Maxigen Biotech and its competitors. For the Medical Devices & Instruments industry, the median Dividend Payout Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maxigen Biotech's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maxigen Biotech stock overvalued right now?
Based on GuruFocus' analysis, Maxigen Biotech (TPE:1783) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$61.11, compared to a current price of NT$39.90 — trading 34.7% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Maxigen Biotech's overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Maxigen Biotech (TPE:1783), the current Dividend Payout Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maxigen Biotech (TPE:1783) Overvalued in 2026?
Based on GuruFocus' analysis, Maxigen Biotech stock appears to be undervalued.
The current stock price of NT$39.90 is trading 34.7% below its estimated GF Value™ of NT$61.11.
GuruFocus considers Maxigen Biotech to be Significantly Undervalued.
Key valuation signals for TPE:1783:
Dividend Payout Ratio: 0.00
GF Value™: NT$61.11 vs. price of NT$39.90 (34.7% below fair value)
No single metric tells the full story. See the TPE:1783 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maxigen Biotech Inc is engaged in collagen purification, research and development, production and sales of implantable medical device, and production, manufacturing, wholesale and retail of cosmetics. The group had two reportable segments: the biomedical products segment and consumer products segment. Biomedical products segment is engaged in the manufacturing and sales of collagen and bone materials. The consumer products segment is involved in the manufacturing and sales of beauty care products. Geographically, it operates in Taiwan, America, Europe, Asia, and other countries, with the majority of the revenue deriving from Taiwan.
87GF Score
Get the complete analysis for TPE:1783
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1783 has been successfully added to your 
